Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas De Jay

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Nature Communications|March 10, 2017
The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppressionRyuhjin Ahn, Valérie Sabourin, Alicia M Bolt, et al.
Cancer Cell|November 7, 2017
H3.3<sup>K27M</sup> Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade GliomasManav Pathania, Nicolas De Jay, Nicola Maestro, et al.
Acta Neuropathologica Communications|November 1, 2017
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomasRalph Salloum, Melissa K McConechy, Leonie G Mikael, et al.
Nature Communications|November 3, 2018
TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jawCarolina Cavalieri Gomes, Tenzin Gayden, Andrea Bajic, et al.
Blood Advances|March 15, 2021
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesiclesNadim Tawil, Rayhaan Bassawon, Brian Meehan, et al.
Nature Communications|June 30, 2019
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressivenessMeaghan Boileau, Margret Shirinian, Tenzin Gayden, et al.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cancer Cell|September 19, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Science (New York, N.Y.)|May 14, 2016
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscapeChao Lu, Siddhant U Jain, Dominik Hoelper, et al.
Cancer Discovery|September 24, 2020
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of BoneSima Khazaei, Nicolas De Jay, Shriya Deshmukh, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Nature Communications|March 10, 2017
The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppressionRyuhjin Ahn, Valérie Sabourin, Alicia M Bolt, et al.
Cancer Cell|November 7, 2017
H3.3<sup>K27M</sup> Cooperates with Trp53 Loss and PDGFRA Gain in Mouse Embryonic Neural Progenitor Cells to Induce Invasive High-Grade GliomasManav Pathania, Nicolas De Jay, Nicola Maestro, et al.
Acta Neuropathologica Communications|November 1, 2017
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomasRalph Salloum, Melissa K McConechy, Leonie G Mikael, et al.
Nature Communications|November 3, 2018
TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jawCarolina Cavalieri Gomes, Tenzin Gayden, Andrea Bajic, et al.
Blood Advances|March 15, 2021
Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesiclesNadim Tawil, Rayhaan Bassawon, Brian Meehan, et al.
Nature Communications|June 30, 2019
Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressivenessMeaghan Boileau, Margret Shirinian, Tenzin Gayden, et al.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cancer Cell|September 19, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Science (New York, N.Y.)|May 14, 2016
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscapeChao Lu, Siddhant U Jain, Dominik Hoelper, et al.
Cancer Discovery|September 24, 2020
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of BoneSima Khazaei, Nicolas De Jay, Shriya Deshmukh, et al.
Pageof 3